Agentix (AGTX) Assets Average (2014 - 2026)
Agentix's (AGTX) quarterly Assets Average came in at $3583.5 in Q1 2026, down 97.18% YoY from $127192.5 in Q1 2025, and down 40.26% on a QoQ basis from $5998.5 in Q4 2025.
Agentix (AGTX) Assets Average (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Assets Average data on file, last reported at $3583.5 in Q1 2026.
- Quarterly Assets Average fell 97.18% year-over-year to $3583.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3583.5 (down 97.18% YoY) and the FY2026 annual result came in at $50522.5, down 51.1% from the prior year.
- Assets Average slipped to $3583.5 in Q1 2026, from $5998.5 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $332102.0 in Q3 2023 to a low of $3583.5 in Q1 2026.
- A 5-year average of $116240.5 and a median of $109161.5 in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average soared 3296.25% — and 2026, when it sank 97.18%.
- Tracing AGTX's Assets Average over 5 years: stood at $60005.0 in 2022, then surged by 271.35% to $222827.5 in 2023, then slipped by 27.28% to $162035.5 in 2024, then sank by 96.3% to $5998.5 in 2025, then tumbled by 40.26% to $3583.5 in 2026.
- The last three Assets Average figures came in at $3583.5 (Q1 2026), $5998.5 (Q4 2025), and $5006.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 19.82 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 404.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 404.50 |
| Mar 31, 2026 | 3,583.50 |
| Dec 31, 2025 | 5,998.50 |
| Sep 30, 2025 | 5,006.50 |
| Jun 30, 2025 | 52,343.00 |
| Mar 31, 2025 | 127,192.50 |
| Dec 31, 2024 | 162,035.50 |
| Sep 30, 2024 | 168,453.00 |
| Jun 30, 2024 | 136,659.00 |
| Mar 31, 2024 | 109,161.50 |
| Dec 31, 2023 | 222,827.50 |
| Sep 30, 2023 | 332,102.00 |
| Jun 30, 2023 | 295,946.00 |
| Mar 31, 2023 | 186,433.50 |
| Dec 31, 2022 | 60,005.00 |
| Sep 30, 2022 | 9,778.50 |
| Jun 30, 2022 | 39,368.00 |
| Feb 28, 2022 | 59,195.00 |
| Nov 30, 2021 | 50,941.50 |
| Aug 31, 2021 | 54,507.50 |